TLSI
TriSalus Life Sciences Inc.
4.30$
+4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 1.3% | 15.9% | 12.6% | 17.9% | 25.3% | 22.2% | 16.7% | 11.3% | 10.2% | 15.0% | 12.4% | 13.7% | 14.7% | 16.3% | 16.1% | 16.5% | 13.3% | 13.8% | 13.2% | 14.2% | |
| – | – | – | 98.7% | 84.1% | 87.4% | 82.1% | 74.7% | 77.8% | 83.3% | 88.7% | 89.8% | 85.0% | 87.6% | 86.3% | 85.3% | 83.7% | 83.9% | 83.5% | 86.7% | 86.2% | 86.8% | 85.8% | |
| – | – | – | 170.3% | 201.1% | 191.7% | 122.6% | 194.3% | 189.1% | 149.3% | 183.1% | 133.5% | 90.7% | 63.4% | 57.4% | 35.8% | 36.0% | 35.0% | 44.8% | 19.5% | 36.1% | 27.5% | 31.3% | |
| – | – | – | 93.6% | 101.8% | 87.5% | 89.1% | 125.8% | 119.0% | 106.2% | 173.8% | 105.1% | 71.7% | 53.7% | 64.3% | 141.2% | 54.2% | 50.5% | 57.6% | 31.6% | 61.3% | 45.2% | 47.6% | |
| – | – | – | 345.6% | 417.1% | 388.4% | 288.9% | 439.6% | 417.0% | 331.2% | 447.1% | 336.6% | 265.9% | 198.6% | 205.3% | 191.8% | 163.6% | 149.3% | 161.5% | 111.4% | 180.7% | 172.8% | 153.5% | |
| – | – | – | -247.0% | -333.0% | -301.1% | -206.8% | -364.9% | -339.2% | -247.9% | -358.5% | -246.8% | -181.0% | -111.0% | -118.9% | -91.8% | -79.9% | -65.4% | -77.9% | -24.8% | -94.5% | -86.0% | -67.7% | |
| – | – | – | 0.3% | 2.4% | 10.9% | 25.9% | 0.0% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 11.9% | 15.5% | 12.9% | 13.2% | 12.7% | 12.6% | 11.0% | 16.1% | 13.1% | 13.0% | |
| – | – | – | -271.3% | -332.2% | -301.5% | -206.3% | -698.6% | -277.2% | -302.7% | -27.4% | -620.7% | -204.7% | -58.7% | -32.7% | -122.4% | -113.1% | -73.9% | -93.4% | -73.9% | 17.3% | -80.5% | -62.6% | |
| – | – | – | 151.5% | -0.1% | 0.1% | 4.9% | 0.2% | -0.2% | 0.3% | -2.2% | 0.0% | 0.0% | 0.1% | 0.0% | – | 0.1% | 0.0% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | |
| – | – | – | -271.3% | -332.2% | -301.6% | -206.3% | -698.8% | -277.1% | -303.0% | -27.4% | -620.7% | -204.7% | -58.8% | -32.6% | -122.4% | -113.2% | -73.9% | -93.5% | -73.9% | 17.3% | -80.5% | -62.6% | |
| – | – | – | -264.9% | -320.6% | -301.3% | -202.4% | -695.5% | -270.9% | -299.4% | -24.4% | -617.1% | -201.7% | -44.0% | -14.8% | – | -98.1% | -59.8% | -79.4% | -61.9% | 35.0% | -65.1% | -48.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.